New pharmaceutical compositions for oral use containing Diclofenac together with
alkali metal bicarbonates in amounts of from 20 to 80 by weight with respect to
Diclofenac are described. These compositions are entirely palatable and free from
any unpleasant taste or other side effects; in particular, these formulations permit
to obtain in human patients higher Cmax of the active principle and
shorter Tmax together with a lower coefficient of variation.
